Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA site-wide NIH banner announces a website transition and a terminology change from “Artificial Intelligence” to “Super Intelligence.” The site revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record details, signaling restricted access to the content. Previous study content and related metadata are no longer visible.SummaryDifference17%

- Check43 days agoChange DetectedThe revision label in the documentation section was updated from v3.6.6 to v3.7.0. This reflects a new revision of the study documents.SummaryDifference0.0%

- Check58 days agoChange DetectedThe revision line now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates an updated version of the study documents or related materials associated with the page.SummaryDifference0.0%

- Check64 days agoChange DetectedA line noting an NIH grant/contract funding source was added to the study details, clarifying the source of support for this risankizumab maintenance trial.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.